The effects of a synthetic thyrotrophin releasing hormone (TRH) in normal and endocrinopathic subjects.
D000238:Adenoma, Chromophobe / Q000097:blood; D000284:Administration, Oral; D004700:Endocrine System Diseases / Q000097:blood*; D005260:Female; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D006980:Hyperthyroidism / Q000097:blood; D007037:Hypothyroidism / Q000097:blood; D007275:Injections, Intravenous; D007457:Iodine Radioisotopes; D008297:Male; D010900:Pituitary Diseases / Q000097:blood; D010911:Pituitary Neoplasms / Q000097:blood; D013964:Thyroid Neoplasms / Q000097:blood; D013972:Thyrotropin / Q000097:blood*; D013973:Thyrotropin-Releasing Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D013974:Thyroxine / Q000097:blood*; D013997:Time Factors
D007457:Iodine Radioisotopes; D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin; D013006:Growth Hormone; D013974:Thyroxine; D006854:Hydrocortisone